Future Watch: Gene & Cell Therapy
A Revolution In Medicine And Healthcare Blog

Future Watch: Gene & Cell Therapy
A Revolution In Medicine And Healthcare Blog

Raising Awareness for Rare Disease Day

Raising Awareness for Rare Disease Day

Feb 28, 2023

Contributing Author Luke Williams, Sales and Marketing  Each year on February 28th we shine a spotlight on rare disease research. There are thousands of rare diseases, and many stem from inheriting a single pathogenic gene. Traditional medicine can make patients comfortable and help ameliorate symptoms,…

Read More
How to Design a Gene Therapy to Target Inherited Diseases

How to Design a Gene Therapy to Target Inherited Diseases

Feb 23, 2023

Contributing Author Luke Williams, Sales and Marketing  The human genome contains approximately 20,000 protein-coding genes. When read, these genes tell a cell how to make a specific protein, which can then be used to perform a cellular process. Variations on any of these genes can…

Read More
Black Pioneers in Biology Who Ushered Us Into the Genetic Age

Black Pioneers in Biology Who Ushered Us Into the Genetic Age

Feb 1, 2023

Contributing Author Luke Williams, Sales and Marketing  Meet the scientists who revolutionized our understanding of biochemistry and reframed the human identity For Black History Month, American Gene Technologies® spotlights four of the many influential Black scientists whose work helped launch the genetic age that is…

Read More
The Biotech Project Podcast Dives into the Passionate Vision of Jeff Galvin

The Biotech Project Podcast Dives into the Passionate Vision of Jeff Galvin

Jan 19, 2023

The Biotech Project podcast hosts Scott J Resnik, MBA, NYS EMT-CC, and John Walsh, MD, sit down with American Gene Technologies® founder and CEO Jeff Galvin for a lively and inspiring discussion.Watch the full episode to follow Jeff’s journey as he builds a company that’s…

Read More
American Gene Technologies Celebrates Another Year of Progress

American Gene Technologies Celebrates Another Year of Progress

Dec 28, 2022

Contributing Author John Vandermosten, Senior Biotechnology Analyst In 2022, the world was collectively compelled to endure a surge in viral outbreaks, the horror of the Russia-Ukraine war and rampant inflation, which has led many to a state of pessimism. But, the dramatic events of 2022 have…

Read More
AGT Phase 1 HIV Clinical Trial Data Published in Frontiers in Medicine

Phase 1 HIV Clinical Trial Data Published in “Frontiers in Medicine” Journal

Dec 22, 2022

Contributing Author Luke Williams, Sales and Marketing  American Gene Technologies® (AGT) designed AGT103-T in hopes of functionally curing HIV. The therapeutic is made of the patient’s own T cells which have been enhanced for HIV resistance, and data from the Phase 1 human trial has…

Read More
Gene Therapy Clinical Trial Requirements

Gene Therapy Clinical Trial Requirements

Dec 7, 2022

Contributing Author John Vandermosten, Senior Biotechnology Analyst Gene Therapy Does It “My Way” In 1990, gene therapy burst onto the world stage with the first clinical trial aimed at a genetic disease.  This effort, led by a team at the National Institute of Health, successfully treated…

Read More
ShareTreck Interviews Jeff Galvin on the Future of Medicine

ShareTreck Host Interviews Jeff Galvin on The Future of Medicine

Nov 28, 2022

Raj Natarajan, host of ShareTreck, goes behind the scenes with Jeff Galvin, Founder and CEO of American Gene™ in this compelling interview learn how gene therapy works, and what it means for people with deadly diseases, as well as how it will impact the current…

Read More
The Future of Gene Therapy

The Future of Gene Therapy

Oct 24, 2022

Contributing Author John Vandermosten, Senior Biotechnology Analyst Economies of scale can apply to gene therapy too Gene therapy’s advantage is its ability to modify the genetic cause of disease. The approach has the potential to correct genetic errors, cure genetic disease and fight serious infections using…

Read More
What is monkeypox?

Monkeypox: Separating Fact from Fiction

Sep 15, 2022

Contributing Author John Vandermosten, Senior Biotechnology Analyst With almost three years of COVID consuming our lives, a reprieve from viral outbreaks seemed deserved. However, that was not to be. A new virulent pathogen known as monkeypox emerged surprisingly quickly earlier this year. In May 2022, a…

Read More

Subscribe to Receive our Blog Updates

Subscribe to our blog updates to be notified when we release new content!

Blog Categories

Follow AGT on Social Media

AGT on Facebook

Jeff Galvin, CEO of American Gene Technologies, shares his journey from Silicon Valley to biotech and the future of gene therapy. Watch the interview on Bio Blast!www.addimmune.com/jeff-galvin-explains-agts-innovative-approach-to-hiv-on-bio-blast/#genetherapy #biotech #innovation ... See MoreSee Less
View on Facebook
Tune in to Cell & Gene: The Podcast and hear Addimmune's Dr. Marcus Conant, a pioneer in HIV research, discuss our innovative cell therapy for HIV. He shares his vision for empowering patients and transforming HIV treatment. loom.ly/96TZ0jU#HIV #celltherapy #biotech ... See MoreSee Less
View on Facebook
M&A has been steady in 2024. We count 47 private & public deals to date totaling $53 billion. 15 have been >$1 billion with cancer, rare disease & cell therapies some of the areas of interest. ... See MoreSee Less
View on Facebook
AGT CEO, Jeff Galvin, had a chat with social media influencer and HIV advocate, Raif Derrazi, to discuss the latest updates on our AGT103-T clinical trials. Dive into the conversation as they shed light on the research and what lies ahead in our mission to find a cure for HIV! loom.ly/jAThqIU#HIV #hivcure #HIVresearch #clinicaltrials ... See MoreSee Less
View on Facebook